National Health Investors (NHI) Receivables (2009 - 2026)

National Health Investors has reported Receivables for 18 years, with the latest figure at $6.6 million in Q1 2026.

• For the quarter ending Q1 2026, Receivables fell 5.17% year-over-year to $6.6 million; the trailing twelve-month figure through Mar 2026 stood at $6.6 million (down 5.17% YoY), and the FY2025 full-year result was $9.3 million, down 42.43% from the prior year.
• Receivables for Q1 2026 stood at $6.6 million, down from $9.3 million in the prior quarter.
• The five-year high for Receivables was $16.2 million in Q4 2024, with the low at $6.6 million in Q1 2023.
• Historically, Receivables has averaged $9.1 million across 5 years, with a median of $7.9 million in 2024.
• Annual changes were most pronounced in 2023 — Receivables jumped 130.28% — and 2025, when it slumped 42.43%.
• National Health Investors' Receivables stood at $6.9 million in 2022, then jumped by 130.28% to $15.9 million in 2023, then advanced by 2.04% to $16.2 million in 2024, then tumbled by 42.43% to $9.3 million in 2025, then dropped by 28.88% to $6.6 million in 2026.
• The last three Receivables figures came in at $6.6 million (Q1 2026), $9.3 million (Q4 2025), and $6.8 million (Q3 2025), per Business Quant data.